MALLESONS Stephen Jaques has acted for HRZ Wheats Pty Ltd on a deal enabling the continued investment in the creation of unique germplasm targeting the high rainfall zone of Australia.
The deal follows equity investment into the company by Dow AgroSciences Australia Ltd.
The CSIRO said research into developing more productive wheat varieties in Australia has been given a major boost following the equity investment in HRZ Wheats Pty Ltd by Dow AgroSciences.
HRZ Wheat's other shareholders are CSIRO, the Grains Research and Development Corporation, Landmark Operations Limited and New Zealand Plant & Food Research.
The investment by Dow AgroSciences, an agricultural chemical and pest control company that also has a strong emphasis on agricultural crops, will enable HRZ Wheats to continue to develop milling quality, disease resistant wheat varieties with a high rate of return for the nation's growers, overcoming the challenges presented by the high rainfall zone, the firm said.
The deal will ensure leading technologies and new germplasm for research and breeding will be made available to HRZ Wheats. Landmark (through Seednet and partners) will be responsible for the seed production and commercialisation of commodity wheat varieties within Australia.
The Mallesons team was led by partner Adam Bartlett and supported by Senior Associate Annabel Griffin.
Mallesons partner Bartlett, said: "This collaboration is a great outcome for all parties, with the additional investment allowing HRZ to expand their research efforts and deliver a superior product to growers with the added input of Dow AgroSciences' knowledge and tools."
The investment into HRZ Wheats will be welcomed by both breeders and growers within the wheat industry globally. Australian growers can expect to see new and superior wheat varieties produced by HRZ Wheat's breeding programs.
Know more? Email the Editor.
Like this story? Read more: